Neonatal outcomes for women at risk of preterm delivery given half dose versus full dose of antenatal betamethasone: a randomised, multicentre, double-blind, placebo-controlled, non-inferiority trial.

Schmitz T, Doret-Dion M, Sentilhes L, Parant O, Claris O, Renesme L, Abbal J, Girault A, Torchin H, Houllier M, Le Saché N, Vivanti AJ, De Luca D, Winer N, Flamant C, Thuillier C, Boileau P, Blanc J, Brevaut V, Bouet PE, Gascoin G, Beucher G, Datin-Dorriere V, Bounan S, Bolot P, Poncelet C, Alberti C, Ursino M, Aupiais C, Baud O, BETADOSE trial study group, Groupe de Recherche en Obstétrique et Gynécologie

Open source

DOI
10.1016/s0140-6736(22)01535-5
Published
2022 Aug 20
Container
Lancet (London, England)
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-22-01535-5,
  title = {Neonatal outcomes for women at risk of preterm delivery given half dose versus full dose of antenatal betamethasone: a randomised, multicentre, double-blind, placebo-controlled, non-inferiority trial.},
  author = {Schmitz T and Doret-Dion M and Sentilhes L and Parant O and Claris O and Renesme L and Abbal J and Girault A and Torchin H and Houllier M and Le Saché N and Vivanti AJ and De Luca D and Winer N and Flamant C and Thuillier C and Boileau P and Blanc J and Brevaut V and Bouet PE and Gascoin G and Beucher G and Datin-Dorriere V and Bounan S and Bolot P and Poncelet C and Alberti C and Ursino M and Aupiais C and Baud O and BETADOSE trial study group and Groupe de Recherche en Obstétrique et Gynécologie},
  year = {2022},
  journal = {Lancet (London, England)},
  doi = {10.1016/s0140-6736(22)01535-5},
  url = {https://doi.org/10.1016/s0140-6736(22)01535-5}
}

RIS

TY  - JOUR
TI  - Neonatal outcomes for women at risk of preterm delivery given half dose versus full dose of antenatal betamethasone: a randomised, multicentre, double-blind, placebo-controlled, non-inferiority trial.
AU  - Schmitz T
AU  - Doret-Dion M
AU  - Sentilhes L
AU  - Parant O
AU  - Claris O
AU  - Renesme L
AU  - Abbal J
AU  - Girault A
AU  - Torchin H
AU  - Houllier M
AU  - Le Saché N
AU  - Vivanti AJ
AU  - De Luca D
AU  - Winer N
AU  - Flamant C
AU  - Thuillier C
AU  - Boileau P
AU  - Blanc J
AU  - Brevaut V
AU  - Bouet PE
AU  - Gascoin G
AU  - Beucher G
AU  - Datin-Dorriere V
AU  - Bounan S
AU  - Bolot P
AU  - Poncelet C
AU  - Alberti C
AU  - Ursino M
AU  - Aupiais C
AU  - Baud O
AU  - BETADOSE trial study group
AU  - Groupe de Recherche en Obstétrique et Gynécologie
PY  - 2022
JO  - Lancet (London, England)
DO  - 10.1016/s0140-6736(22)01535-5
UR  - https://doi.org/10.1016/s0140-6736(22)01535-5
ER  - 

APA

T, S., M, D., L, S., O, P., O, C., L, R., J, A., A, G., H, T., M, H., N, L. S., AJ, V., D, D. L., N, W., C, F., C, T., P, B., J, B., V, B., PE, B., G, G., G, B., V, D., S, B., P, B., C, P., C, A., M, U., C, A., O, B., group, B. T. S., & Gynécologie, G. D. R. E. O. E. (2022). Neonatal outcomes for women at risk of preterm delivery given half dose versus full dose of antenatal betamethasone: a randomised, multicentre, double-blind, placebo-controlled, non-inferiority trial.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(22)01535-5

Source records